NIH Awards Lucigen $2.8M SBIR Grant for POC Influenza Test - GenomeWeb

Genetic Engineering News

NIH Awards Lucigen $2.8M SBIR Grant for POC Influenza Test GenomeWeb based company, will go toward the development of a molecular test for influenza A and B and respiratory syncytial virus. It will be able to test multiple RNA pathogens, Lucigen said. "The combination of novel molecular technologies, simple protocol, ... Lucigen receives $2.8M NIH grantThe Business Journal all 16 news articles »

Tech and Biotech: Lucigen Corp. gets grant for influenza test - Wisconsin State Journal

Tech and Biotech: Lucigen Corp. gets grant for influenza test Wisconsin State Journal The test will screen for influenza A and B and for respiratory syncytial virus, or RSV, which can be serious in premature babies or young children with other diseases. Lucigen sells enzymes and cloning kits to scientists; the test for flu will take the ... and more »

Lucigen receives grant to develop influenza screen - Vaccine News Daily (blog)

Lucigen receives grant to develop influenza screen Vaccine News Daily (blog) When completed, the test will screen for influenza A and B, as well as for respiratory syncytial virus. Lucigen is known for marketing enzymes and cloning kits to scientists. The test is expected to take the company in a new direction, according to ... and more »

Swine Flu Vaccine Found To Give Broader Flu Protection - RedOrbit

RedOrbit

Swine Flu Vaccine Found To Give Broader Flu Protection RedOrbit In the study, the scientists saw that the majority of flu antibodies neutralized more than one influenza strain. This strength in neutralization could have been the result of B-cell memory from previous exposure to other flu strains. Pandemic 2009 H1N1 vaccination produces antibodies against multiple flu strainsEurekAlert (press release) Study: Obesity not a risk factor for medically attended fluCIDRAP Swine flu vaccine yields clues to universal vaccineMother Nature Network BioResearch Online (press release) all 116 news articles »

Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent ... - MarketWatch (press release)

Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent ... MarketWatch (press release) "We believe that a quadrivalent Fluzone vaccine could provide an important public health benefit for people of all ages by providing coverage against an extra B virus strain of influenza. Influenza B is responsible for a substantial burden of disease ... and more »